Traditional Chinese medicinal composition for improving cerebral thrombosis

Abstract

A traditional Chinese medicinal composition for improving cerebral thrombosis is prepared from the following raw materials in parts by weight: 10 to 20 parts of black nightshade, 10 to 20 parts of ajuga ciliate, 10 to 20 parts of cordate houttuynia, 10 to 20 parts of blackberry, 8 to 17 parts of coptis chinensis, 7 to 15 parts of hedyotis diffusa, 7 to 15 parts of herba lycopi, 7 to 15 parts of curcuma aromatic, 7 to 15 parts of psychotria serpens, 7 to 15 parts of pseudo-ginseng, 5 to 13 parts of isatis root, 5 to 13 parts of gold line vine, 5 to 13 parts of lysimachia christinae hance, 1 to 3 parts of polygonum cuspidatum and 1 to 3 parts of plantago asiatica. The traditional Chinese medicinal composition has a good effect of improving the early-stage symptom of the cerebral thrombosis.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for improving cerebral thrombosis. Background technique [0002] Cerebral thrombosis is the most common type of cerebral infarction. Atherosclerosis of the main cerebral artery or cortical branch leads to thickening of blood vessels, stenosis and occlusion of the lumen, and thrombosis, resulting in reduced or interrupted blood flow in the brain, cerebral ischemia and hypoxia leading to softening and necrosis, and focal neurological symptoms . [0003] Cerebral thrombosis has three major characteristics, first, blood coagulation, second, slow blood flow, third, arteriosclerosis, abnormal blood images, and blood coagulation, which are manifested by humidity, heat, fat, polysaccharide, polyprotein, and high cholesterol in the patient's body , less nutrition, less fiber, lack of Qi and blood, slow blood flow, blocked ...

AI Technical Summary

Problems solved by technology

[0006] At present, most of the treatment of cerebral thrombosis is based on western medicine, or the direction of reducing blood coagulation, but the root cause of cerebral thrombosis is ignored. At present, there is no drug that can improve the early symptoms of cerebral thrombosis from the root.